FDA Inspection 823531 — Nuvo Pharmaceuticals Inc.

Nuvo Pharmaceuticals Inc. — FEI 3003242976

The FDA completed an inspection of Nuvo Pharmaceuticals Inc. on Feb 28, 2013 in Varennes. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 28, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Varennes (Canada)